Zymar (Gatifloxacin ophthalmic solution, 0.3%)

News
Article

Fluoroquinolone approved for bacterial conjunctivitis

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!
Recent Videos
Related Content
FDA Approves Eydenzelt, Additional Eylea Biosimilar

FDA Approves Eydenzelt, Additional Eylea Biosimilar

Logan Lutton
October 11th 2025
Article

Read More

Nancy Lurker of EyePoint Pharmaceuticals Addresses Innovations in Eye Care, How to Grow in the C-Suite and What it Takes to Run a Biopharma Company

Nancy Lurker of EyePoint Pharmaceuticals Addresses Innovations in Eye Care, How to Grow in the C-Suite and What it Takes to Run a Biopharma Company

Briana Contreras
October 11th 2025
Podcast

Listen

Repatha Now Available for Approximately 60% Off List Price

Repatha Now Available for Approximately 60% Off List Price

Logan Lutton
October 11th 2025
Article

Read More

David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2

David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2

Briana Contreras
October 11th 2025
Podcast

Listen

Changes in the Eye’s Blood Vessels Could Signal Early Risk for Alzheimer’s and Related Dementias

Changes in the Eye’s Blood Vessels Could Signal Early Risk for Alzheimer’s and Related Dementias

Briana Contreras
October 11th 2025
Article

Read More

Novo Nordisk Resubmits BLA for Once-Weekly Insulin for Type 2 Diabetes

Novo Nordisk Resubmits BLA for Once-Weekly Insulin for Type 2 Diabetes

Denise Myshko
October 11th 2025
Article

Read More

© 2025 MJH Life Sciences

All rights reserved.